MADRIGAL PHARMACEUTICALS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Madrigal Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q2 2024.
  • Madrigal Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $24.4M, a 122% increase year-over-year.
  • Madrigal Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $71.8M, a 86.9% increase year-over-year.
  • Madrigal Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $49.7M, a 57.3% increase from 2022.
  • Madrigal Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $31.6M, a 17.7% increase from 2021.
  • Madrigal Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $26.9M, a 29.6% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $71.8M $24.4M +$13.4M +122% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $58.4M $19.9M +$8.65M +76.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $49.7M $14.9M +$6.77M +83.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $43M $12.7M +$4.54M +55.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $38.4M $11M +$3.03M +38.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $35.4M $11.3M +$3.77M +50.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $31.6M $8.08M +$1.73M +27.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $29.9M $8.12M +$1.88M +30.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 $28M $7.94M -$235K -2.87% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $28.3M $7.48M +$1.38M +22.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $26.9M $6.36M +$1.22M +23.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $25.7M $6.24M +$1.18M +23.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $24.5M $8.18M +$2.49M +43.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $22M $6.1M +$1.25M +25.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $20.7M $5.13M +$1.1M +27.3% Oct 1, 2020 Dec 31, 2020 10-K/A 2023-03-03
Q3 2020 $19.6M $5.06M +$111K +2.24% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $19.5M $5.69M -$2.07M -26.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $21.6M $4.85M -$1.18M -19.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $22.8M $4.03M -$1.09M -21.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $23.8M $4.95M -$26K -0.52% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $23.9M $7.76M +$5.53M +248% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $18.3M $6.02M +$4.86M +416% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $13.5M $5.12M +$4.17M +441% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $9.32M $4.98M +$3.95M +384% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $5.37M $2.23M +$1.55M +229% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $3.82M $1.17M +$565K +93.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $3.25M $947K +$1.36M Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 $1.89M $1.03M -$6.32M -86% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $8.21M $676K +$131K +24% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $8.08M $602K +$154K +34.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $7.93M -$417K -$996K -172% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 $8.93M $7.35M +$6.19M +530% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $2.74M $545K -$298K -35.4% Apr 1, 2016 Jun 30, 2016 10-Q 2016-07-20
Q1 2016 $3.04M $448K -$1.26M -73.8% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $4.3M $579K -$1.19M -67.2% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-15
Q3 2015 $5.49M $1.17M -$398K -25.4% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $5.89M $843K -$670K -44.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-20
Q1 2015 $6.56M $1.71M -$876K -33.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $7.43M $1.77M +$226K +14.7% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 $7.21M $1.57M -$117K -6.95% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $7.32M $1.51M -$78K -4.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $7.4M $2.59M +$1.37M +113% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $6.03M $1.54M +$577K +59.9% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 $5.45M $1.68M +$882K +110% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 $4.57M $1.59M +$860K +118% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 $3.71M $1.22M +$389K +47% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $3.32M $963K Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 $801K -$66K -7.61% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-04
Q2 2012 $731K -$81K -9.98% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-01
Q1 2012 $827K Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-30
Q3 2011 $867K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $812K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.